Besim Ogretmen to Molecular Targeted Therapy
This is a "connection" page, showing publications Besim Ogretmen has written about Molecular Targeted Therapy.
Connection Strength
0.063
-
Targeting glutamine-addiction and overcoming CDK4/6 inhibitor resistance in human esophageal squamous cell carcinoma. Nat Commun. 2019 03 21; 10(1):1296.
Score: 0.037
-
Targeting sphingosine kinase induces apoptosis and tumor regression for KSHV-associated primary effusion lymphoma. Mol Cancer Ther. 2014 Jan; 13(1):154-64.
Score: 0.026